Anakinra treatment for refractory cerebral autoinflammatory responses

Refractory cerebral autoinflammatory–autoimmune diseases are often associated with dysregulated innate immunity and are targeted by anakinra, an interleukin‐1 receptor antagonist. We analyzed the therapeutic effect of anakinra in refractory cerebral autoinflammatory response (CAIR) at a single insti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Yoonhyuk, Lee, Woo‐Jin, Lee, Han Sang, Chu, Kon, Lee, Sang Kun, Lee, Soon‐Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791800/
https://www.ncbi.nlm.nih.gov/pubmed/35040583
http://dx.doi.org/10.1002/acn3.51500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791800/
https://www.ncbi.nlm.nih.gov/pubmed/35040583
http://dx.doi.org/10.1002/acn3.51500

Ejemplares similares